Rare apolipoprotein E variant identified in a patient with Type III hyperlipidaemia
- 作者Philip R. Wenham; Ian F.W. McDowell; Vivien M. Hodges; Jane McEneny; Maurice J. O'Kane; R. Jeremy; H. Davies; D. Paul Nicholls; Elisabeth R. Trimble; Gillian Blundell
- 卷第99卷
- 期第2期
- 文件大小1172.90KB
- 发表时间1993
- DOI10.1016/0021-9150(93)90028-s
- 页码261-271
Neopterin levels in patients with coronary artery disease are independent of chlamydia pneumoniae seropositivityDavid A Smith; Emmanouil G Zouridakis; Matteo Mariani; Salim Fredericks; Della Cole; Juan Carlos Kaski · 2003
Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery diseasePablo Avanzas; Ramón Arroyo-Espliguero; Juan Cosin-Sales; Juan Quiles; Emmanouil Zouridakis; Juan Carlos Kaski · 2004
Evaluation of serum neopterin levels in patients with chronic coronary artery disease and hyperlipidaemia before and after lipid lowering treatmentKiriakou, P.; Papadopoulos, T.; Salame, M.; Dhar, S.; Steele, H.; Ecob, R.; Haq, I.; Oakley, D. · Atherosclerosis Supplements · 2001
ASSOCIATION OF CIRCULATING LEVELS OF NEOPTERIN WITH PLAQUE VULNERABILITY IN PATIENTS WITH CORONARY ARTERY DISEASE AN ANGIOGRAM, OPTICAL COHERENT TOMOGRAPHY AND INTRAVASCULAR ULTRASOUND STUDYHe, Jieqiong; Tian, Jinwei; Yu, Bo · Journal of the American College of Cardiology · 2015
Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end productsDouwe J. Mulder; Paul L. van Haelst; Sascha Gross; Karina de Leeuw; Johan Bijzet; Reindert Graaff; Rijk O. Gans; Felix Zijlstra; Andries J. Smit · 2008